Speaker, “Biosimilars and Follow-On Biologics,”

"*" indicates required fields

Name*

First Last

Phone Number*

Email Address*

How can we help you?*

This field used to prevent automated submissions, do not fill out

This field is for validation purposes and should be left unchanged.

Federal Circuit Refuses to Consider Disease Variants as Species of a Disease Genus for Method of Treatment Patents
A Proposal to Address the U.S. Patent “Thicket” Problem During Examination
Capuano IP Launches New Website
Alnylam Pharms, Inc. v. Dicerna Pharms, Inc. (15-04126-EPL) (Mass. Sup. Ct.)

120 Washington St.
Salem, MA 01970

Attorney Advertising | Disclaimer | Privacy Policy
Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 703.992.4580